Literature DB >> 2239290

Use of a long acting somatostatin analogue in controlling ileostomy diarrhoea in infants.

T Lamireau1, R I Galpérine, P Ohlbaum, J L Demarquez, P Vergnes, Y Kurzenne, J P Hehunstre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2239290     DOI： 10.1111/j.1651-2227.1990.tb11572.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN： 0001-656X


× No keyword cloud information.
  6 in total

Review 1.  Ileostomy diarrhea: Pathophysiology and management.

Authors:  Kyle M Rowe; Lawrence R Schiller
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-30

Review 2.  Clinical use of the long acting somatostatin analogue octreotide in pediatrics.

Authors:  M T Tauber; A G Harris; P Rochiccioli
Journal:  Eur J Pediatr       Date:  1994-05       Impact factor: 3.183

Review 3.  Octreotide in the treatment of refractory diarrhoea and intestinal fistulae.

Authors:  M J Farthing
Journal:  Gut       Date:  1994       Impact factor: 23.059

Review 4.  Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.

Authors:  A G Harris
Journal:  Gut       Date:  1994       Impact factor: 23.059

5.  Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia.

Authors:  Siham Al Sinani; Yusria Al Rawahi; Hamed Abdoon
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

6.  Therapeutic applications of octreotide in pediatric patients.

Authors:  Abdulrahman Al-Hussaini; Decker Butzner
Journal:  Saudi J Gastroenterol       Date:  2012 Mar-Apr       Impact factor: 2.485
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.